These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

544 related articles for article (PubMed ID: 26619808)

  • 41. Apolipoprotein E, epsilon 4 allele as a major risk factor for sporadic early and late-onset forms of Alzheimer's disease: analysis of the 19q13.2 chromosomal region.
    Chartier-Harlin MC; Parfitt M; Legrain S; Pérez-Tur J; Brousseau T; Evans A; Berr C; Vidal O; Roques P; Gourlet V
    Hum Mol Genet; 1994 Apr; 3(4):569-74. PubMed ID: 8069300
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Apolipoprotein E4 allele and Alzheimer disease: examination of allelic association and effect on age at onset in both early- and late-onset cases.
    Locke PA; Conneally PM; Tanzi RE; Gusella JF; Haines JL
    Genet Epidemiol; 1995; 12(1):83-92. PubMed ID: 7713402
    [TBL] [Abstract][Full Text] [Related]  

  • 43. An 1H-MRS framework predicts the onset of Alzheimer's disease symptoms in PSEN1 mutation carriers.
    Londono AC; Castellanos FX; Arbelaez A; Ruiz A; Aguirre-Acevedo DC; Richardson AM; Easteal S; Lidbury BA; Arcos-Burgos M; Lopera F
    Alzheimers Dement; 2014 Sep; 10(5):552-61. PubMed ID: 24239247
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The
    Almkvist O; Graff C
    Genes (Basel); 2021 Dec; 12(12):. PubMed ID: 34946903
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cholesteryl ester transfer protein (CETP) polymorphism modifies the Alzheimer's disease risk associated with APOE epsilon4 allele.
    Rodríguez E; Mateo I; Infante J; Llorca J; Berciano J; Combarros O
    J Neurol; 2006 Feb; 253(2):181-5. PubMed ID: 16096813
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Association between apolipoprotein E polymorphism and Alzheimer disease in Tehran, Iran.
    Raygani AV; Zahrai M; Raygani AV; Doosti M; Javadi E; Rezaei M; Pourmotabbed T
    Neurosci Lett; 2005 Feb; 375(1):1-6. PubMed ID: 15664112
    [TBL] [Abstract][Full Text] [Related]  

  • 47. No association or linkage between an intronic polymorphism of presenilin-1 and sporadic or late-onset familial Alzheimer disease.
    Scott WK; Yamaoka LH; Locke PA; Rosi BL; Gaskell PC; Saunders AM; Conneally PM; Small GW; Farrer LA; Growdon JH; Roses AD; Pericak-Vance MA; Haines JL
    Genet Epidemiol; 1997; 14(3):307-15. PubMed ID: 9181359
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Depression, delusions, and hallucinations in Alzheimer's disease: no relationship to apolipoprotein E genotype.
    Lyketsos CG; Baker L; Warren A; Steele C; Brandt J; Steinberg M; Kopunek S; Baker A
    J Neuropsychiatry Clin Neurosci; 1997; 9(1):64-7. PubMed ID: 9017530
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Apolipoprotein E and Alzheimer's disease: strength of association is related to age at onset.
    Murman DL; Foster NL; Kilgore SP; McDonagh CA; Fink JK
    Dementia; 1996; 7(5):251-5. PubMed ID: 8872415
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Retinal Imaging Findings in Carriers With PSEN1-Associated Early-Onset Familial Alzheimer Disease Before Onset of Cognitive Symptoms.
    Armstrong GW; Kim LA; Vingopoulos F; Park JY; Garg I; Kasetty M; Silverman RF; Zeng R; Douglas VP; Lopera F; Baena A; Giraldo M; Norton D; Cronin-Golomb A; Arboleda-Velasquez JF; Quiroz YT; Miller JB
    JAMA Ophthalmol; 2021 Jan; 139(1):49-56. PubMed ID: 33180114
    [TBL] [Abstract][Full Text] [Related]  

  • 51. TOMM40 rs10524523 polymorphism's role in late-onset Alzheimer's disease and in longevity.
    Maruszak A; Pepłońska B; Safranow K; Chodakowska-Żebrowska M; Barcikowska M; Zekanowski C
    J Alzheimers Dis; 2012; 28(2):309-22. PubMed ID: 22008263
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The SIRT2 polymorphism rs10410544 and risk of Alzheimer's disease in two Caucasian case-control cohorts.
    Polito L; Kehoe PG; Davin A; Benussi L; Ghidoni R; Binetti G; Quadri P; Lucca U; Tettamanti M; Clerici F; Bagnoli S; Galimberti D; Nacmias B; Sorbi S; Guaita A; Scarpini E; Mariani C; Forloni G; Albani D
    Alzheimers Dement; 2013 Jul; 9(4):392-9. PubMed ID: 22651940
    [TBL] [Abstract][Full Text] [Related]  

  • 53. APOE2 and consanguinity: a risky combination for Alzheimer's disease.
    Kaur M; Balgir PP
    J Alzheimers Dis; 2005 Dec; 8(3):293-7. PubMed ID: 16340087
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mitochondrial DNA haplogroups and APOE4 allele are non-independent variables in sporadic Alzheimer's disease.
    Carrieri G; Bonafè M; De Luca M; Rose G; Varcasia O; Bruni A; Maletta R; Nacmias B; Sorbi S; Corsonello F; Feraco E; Andreev KF; Yashin AI; Franceschi C; De Benedictis G
    Hum Genet; 2001 Mar; 108(3):194-8. PubMed ID: 11354629
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Definition of Late Onset Alzheimer's Disease and Anticipation Effect of Genome-Wide Significant Risk Variants: Pilot Study of the APOE e4 Allele.
    De Luca V; Spalletta G; Souza RP; Graff A; Bastos-Rodrigues L; Camargos Bicalho MA
    Neuropsychobiology; 2019; 77(1):8-12. PubMed ID: 30110694
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Rare Genetic Variant in SORL1 May Increase Penetrance of Alzheimer's Disease in a Family with Several Generations of APOE-ɛ4 Homozygosity.
    Louwersheimer E; Cohn-Hokke PE; Pijnenburg YA; Weiss MM; Sistermans EA; Rozemuller AJ; Hulsman M; van Swieten JC; van Duijn CM; Barkhof F; Koene T; Scheltens P; Van der Flier WM; Holstege H
    J Alzheimers Dis; 2017; 56(1):63-74. PubMed ID: 27911290
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Metabolic interaction between ApoE genotype and onset age in Alzheimer's disease: implications for brain reserve.
    Mosconi L; Herholz K; Prohovnik I; Nacmias B; De Cristofaro MT; Fayyaz M; Bracco L; Sorbi S; Pupi A
    J Neurol Neurosurg Psychiatry; 2005 Jan; 76(1):15-23. PubMed ID: 15607989
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The Alzheimer's prevention initiative composite cognitive test score: sample size estimates for the evaluation of preclinical Alzheimer's disease treatments in presenilin 1 E280A mutation carriers.
    Ayutyanont N; Langbaum JB; Hendrix SB; Chen K; Fleisher AS; Friesenhahn M; Ward M; Aguirre C; Acosta-Baena N; Madrigal L; Muñoz C; Tirado V; Moreno S; Tariot PN; Lopera F; Reiman EM
    J Clin Psychiatry; 2014 Jun; 75(6):652-60. PubMed ID: 24816373
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Apolipoprotein E-epsilon4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology associated with Alzheimer's disease.
    Premkumar DR; Cohen DL; Hedera P; Friedland RP; Kalaria RN
    Am J Pathol; 1996 Jun; 148(6):2083-95. PubMed ID: 8669492
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Apolipoprotein E genotype in patients with Alzheimer's disease: implications for the risk of dementia among relatives.
    Farrer LA; Cupples LA; van Duijn CM; Kurz A; Zimmer R; Müller U; Green RC; Clarke V; Shoffner J; Wallace DC
    Ann Neurol; 1995 Nov; 38(5):797-808. PubMed ID: 7486872
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.